Aihe-ehdotuksia
Aihe-ehdotuksia
- Development
- Vaccines
- Vaccination 57
- prevention & control 43
- Research 38
- Drug Discovery 34
- isolation & purification 30
- methods 30
- immunology 28
- Vaccines industry 24
- virology 20
- COVID-19 18
- COVID-19 (Disease) 18
- SARS-CoV-2 18
- COVID-19 Vaccines 17
- standards 15
- Clinical Trials as Topic 14
- Prevention 13
- Drug Development 12
- Coronavirus infections 11
- Betacoronavirus 10
- Biomedical Research 10
- Drug Industry 10
- epidemiology 10
- Coronavirus Infections 9
- Viral Vaccines 9
- Coronaviruses 8
- Cost of Illness 8
- Drug Design 8
- Health Services Needs and Demand 8
-
1
How HIV causes disease part 2 of 2, immune responses to HIV infection /
Julkaistu 2019Hae kokoteksti
Series
Elektroninen Video -
2
Rheumatic fever a model of a post-infectious autoimmune disease /
Julkaistu 2019Hae kokoteksti
Series
Elektroninen Video -
3
-
4
-
5
-
6
-
7
Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 1 of 2) /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
8
Regulatory considerations for vaccine development, talk 1 chemistry, manufacturing and control /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
9
Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 2 of 2) /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
10
Bacterial vaccines in development part 1 of 2 /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
11
Bacterial vaccines in development part 2 of 2 /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
12
-
13
-
14
Developing tuberculosis vaccines challenges and strategies, part 1 of 2 /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
15
-
16
Developing tuberculosis vaccines challenges and strategies, part 2 of 2 /
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
17
Respiratory syncytial virus vaccine development
Julkaistu 2015Hae kokoteksti
Series
Elektroninen Video -
18
-
19
-
20
